Understanding the causes of a specific type of dementia in older adults

Molecular and cellular underpinnings of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC)

NIH-funded research Brigham and Women's Hospital · NIH-10907813

This study is looking into a type of brain change that can cause dementia in older adults, aiming to find out what happens at the molecular level so we can better diagnose and treat this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10907813 on NIH RePORTER

What this research studies

This research investigates limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC), a significant cause of dementia in older adults. The study aims to uncover the molecular and cellular changes associated with LATE-NC, which could help in developing models for diagnosis and treatment. By analyzing genetic and transcriptomic data, researchers hope to identify specific pathways and biomarkers related to this condition. This work is crucial for advancing our understanding of dementia and improving patient care.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults aged 80 and over who are experiencing symptoms of dementia.

Not a fit: Patients with forms of dementia unrelated to TDP-43 pathology may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and treatment options for patients suffering from LATE-NC and related dementias.

How similar studies have performed: While LATE-NC is a relatively new area of study, similar research on other forms of dementia has shown promise in identifying molecular targets for treatment.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.